What is ELOXD's earnings per share (EPS)?

ELOXD (ELOXD) reported diluted earnings per share of -$5.34 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ELOXD Financials

ELOXD

FY2025 annual

Revenue $0 -100.0% YoY

Net Income -$6.0M -90.7% YoY

EPS (Diluted) -$5.34 YoY not available

Operating Cash Flow -$6.3M -34.2% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Jun 4, 2026 Currency USD FYE December

Newest figures come from the 10-K for Q1 FY2026, filed Jun 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ELOXD SEC filings page.

ELOXD (ELOXD) reported $0 in revenue for fiscal year 2025, down 100.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

ELOXD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

1/8

ELOXD passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). No profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

ELOXD reported a net loss of $6.0M while operations used $6.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income

-$3.8M

YoY-119.7%

ELOXD reported -$3.8M in net income in Q1 2026. This represents a decrease of 119.7% from the same quarter a year earlier.

EPS (Diluted)

-$0.86

ELOXD earned -$0.86 per diluted share (EPS) in Q1 2026.

Revenue

Not reported for Q1 2026.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt

$6.4M

YoY+1314.0%

QoQ+33.0%

5Y CAGR-22.3%

ELOXD held $6.4M in cash as of Q1 2026; long-term debt is not reported for that period.

Shares Outstanding

ELOXD had 5M shares outstanding in Q1 2026.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

None of these metrics is reported for Q1 2026.

Capital Allocation

R&D Spending

$1.7M

YoY+225.3%

ELOXD invested $1.7M in research and development in Q1 2026. This represents an increase of 225.3% from the same quarter a year earlier.

Share Buybacks

Not reported for Q1 2026.

Capital Expenditures

Not reported for Q1 2026.

ELOXD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ELOXD quarterly income statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$0-100.0%	$6.4M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$182K+2230.6%	$8K-96.1%	$200K	N/A
R&D Expenses	$3.1M-14.6%	$3.6M	N/A	$23.7M+3.6%	$22.9M+56.9%	$14.6M-44.6%	$26.3M+28.6%	$20.5M+24.9%	$16.4M+82.5%	$9.0M+53.8%	$5.8M+75.0%	$3.3M+60.0%	$2.1M-18.7%	$2.6M-31.0%	$3.7M
SG&A Expenses	$3.4M-35.6%	$5.3M	N/A	$10.7M-47.7%	$20.4M+37.7%	$14.8M-38.7%	$24.2M-8.6%	$26.5M+880.1%	$2.7M+216.4%	$854K+93.2%	$442K-88.0%	$3.7M+47.4%	$2.5M-8.2%	$2.7M+4.4%	$2.6M
Operating Income	-$6.4M-160.9%	-$2.5M	N/A	-$34.4M+47.9%	-$66.0M-97.3%	-$33.5M+33.8%	-$50.6M-6.3%	-$47.6M-133.3%	-$20.4M-107.2%	-$9.8M-56.6%	-$6.3M+31.3%	-$9.1M-96.7%	-$4.7M+14.1%	-$5.4M+31.7%	-$7.9M
EBITDA	-$6.4M-164.6%	-$2.4M	N/A	-$34.3M+47.9%	-$65.9M-97.4%	-$33.4M+33.8%	-$50.5M-6.6%	-$47.3M-132.7%	-$20.3M-108.7%	-$9.7M-59.6%	-$6.1M+30.6%	-$8.8M-101.9%	-$4.4M+15.5%	-$5.2M+33.7%	-$7.8M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$43K+514.3%	$7K-94.3%	$122K	N/A	$48K	$0	$0
Income Tax	$0	$0	$0	$0	$0	$0	$0-100.0%	$122K+119.1%	-$640K+5.9%	-$680K	$0	$0	N/A	N/A	N/A
Net Income	-$6.0M-90.7%	-$3.1M	N/A	-$36.1M+46.0%	-$66.7M-93.0%	-$34.6M+32.0%	-$50.9M-7.8%	-$47.2M-122.4%	-$21.2M-115.4%	-$9.8M-53.7%	-$6.4M+30.6%	-$9.2M-50.7%	-$6.1M-20.9%	-$5.1M+30.3%	-$7.3M
EPS (Basic)	-$5.34+42.0%	-$9.20+87.4%	-$72.98-338.3%	-$16.65+56.4%	-$38.15	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	-$5.34	-$9.20+87.4%	-$72.98	-$16.65+56.4%	-$38.15	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	1M	341,708+46.2%	233,670	2M+23.9%	2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-K	Q4'2510-K	Q1'2510-K	Q4'2410-K	Q4'2310-K	Q3'23	Q2'23	Q1'23
R&D Expenses	$1.7M+225.3%	N/A	$510K	N/A	N/A	$1.3M-74.4%	$2.3M-69.4%	$3.5M-55.8%
SG&A Expenses	$2.1M+200.0%	N/A	$712K	N/A	N/A	$2.4M+5.5%	$1.8M-31.9%	$2.0M-34.7%
Operating Income	-$3.8M-210.6%	N/A	-$1.2M	N/A	N/A	-$3.6M+49.1%	-$4.1M+59.8%	-$5.5M+49.9%
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$5.5M+50.0%
Interest Expense	$100K-80.0%	N/A	$500K	N/A	N/A	N/A	N/A	N/A
Net Income	-$3.8M-119.7%	N/A	-$1.7M	N/A	N/A	-$3.6M+52.2%	-$4.3M+59.1%	-$6.2M+46.4%
EPS (Basic)	-$0.86+82.6%	N/A	-$4.94	N/A	N/A	-$1.31+62.2%	-$1.96+60.0%	-$2.88+46.3%
EPS (Diluted)	-$0.86	N/A	-$4.94	N/A	N/A	-$1.31	-$1.96	-$2.88
Diluted Shares (Avg)	4M	N/A	345,958	N/A	N/A	3M	2M	2M

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Income Tax.

ELOXD Balance Sheet

ELOXD quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$5.3M+77.1%	$3.0M+73.8%	$1.7M-91.9%	$21.1M-53.2%	$45.1M+70.5%	$26.5M-55.1%	$58.9M+16.2%	$50.7M+104.6%	$24.8M+692.3%	$3.1M-80.0%	$15.6M-53.1%	$33.3M+369.7%	$7.1M+2.1%	$7.0M-19.1%	$8.6M
Current Assets	$5.3M+77.1%	$3.0M+92.2%	$1.5M-92.3%	$20.1M-53.7%	$43.5M+67.9%	$25.9M-55.1%	$57.7M+14.6%	$50.3M+105.4%	$24.5M+693.8%	$3.1M+14.8%	$2.7M-62.8%	$7.2M+105.2%	$3.5M-0.8%	$3.5M-29.8%	$5.1M
Cash & Equivalents	$4.8M+4210.8%	$111K-90.2%	$1.1M-94.1%	$19.2M-54.6%	$42.3M+71.3%	$24.7M+9.7%	$22.5M-53.7%	$48.6M+102.1%	$24.0M+987.2%	$2.2M+61.5%	$1.4M-77.6%	$6.1M+281.4%	$1.6M-19.9%	$2.0M-44.6%	$3.6M
Short-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$43K	$0	N/A	N/A
Long-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$3.0M-78.6%	$13.9M	$0	N/A	N/A
Total Liabilities	$17.2M-37.1%	$27.3M+12.3%	$24.3M-23.5%	$31.8M+39.7%	$22.8M+40.1%	$16.2M-28.5%	$22.7M+191.2%	$7.8M+128.1%	$3.4M+15.5%	$3.0M-80.2%	$15.0M+156.7%	$5.8M+76.5%	$3.3M-5.4%	$3.5M-14.2%	$4.1M
Current Liabilities	$17.2M-37.1%	$27.3M+20.3%	$22.7M-1.7%	$23.1M+132.0%	$10.0M+1.2%	$9.8M-16.7%	$11.8M+51.2%	$7.8M+128.1%	$3.4M+35.9%	$2.5M+342.4%	$569K-68.8%	$1.8M-43.2%	$3.2M+1.5%	$3.2M-3.2%	$3.3M
Non-Current Liabilities	$0	$0-100.0%	$1.6M-81.4%	$8.7M-32.1%	$12.8M+99.7%	$6.4M-41.3%	$10.9M	$0	$0-100.0%	$446K-96.9%	$14.4M+259.0%	$4.0M+3930.7%	$100K-70.5%	$339K-58.3%	$811K
Long-Term Debt	$0	$0-100.0%	$1.6M-81.2%	$8.6M-28.7%	$12.0M+88.1%	$6.4M-39.3%	$10.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$11.9M+51.1%	-$24.3M-7.7%	-$22.6M-112.0%	-$10.7M-147.6%	$22.4M+118.8%	$10.2M-71.8%	$36.2M-15.6%	$42.9M+100.9%	$21.4M+3401.8%	$610K-5.1%	$643K-97.7%	$27.5M+626.1%	$3.8M+9.6%	$3.5M-23.6%	$4.5M
Retained Earnings	-$300.6M-2.0%	-$294.6M-1.1%	-$291.4M-6.2%	-$274.4M-15.1%	-$238.3M-38.9%	-$171.6M-25.2%	-$137.0M-59.1%	-$86.1M-121.1%	-$39.0M-119.5%	-$17.7M	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-K	Q4'2510-K	Q1'2510-K	Q4'2410-K	Q4'2310-K	Q3'23	Q2'23	Q1'23
Total Assets	$8.5M	$5.3M+77.1%	N/A	$3.0M+73.8%	$1.7M-91.9%	$6.0M-77.5%	$6.0M-81.8%	$7.2M-83.5%
Current Assets	$8.5M	$5.3M+77.1%	N/A	$3.0M+92.2%	$1.5M-92.3%	$5.6M-78.1%	$5.4M-83.0%	$6.4M-84.8%
Cash & Equivalents	$6.4M+1314.0%	$4.8M+4210.8%	$450K	$111K-90.2%	$1.1M-94.1%	$4.8M-80.6%	$4.3M-85.6%	$4.9M-87.7%
Total Liabilities	$16.1M	$17.2M-37.1%	N/A	$27.3M+12.3%	$24.3M-23.5%	$26.1M-18.1%	$24.6M-21.0%	-$9.1M-128.5%
Current Liabilities	$16.1M	$17.2M-37.1%	N/A	$27.3M+20.3%	$22.7M-1.7%	$23.5M+8.2%	$21.3M+9.0%	$19.5M+1.5%
Non-Current Liabilities	$0	$0	N/A	$0-100.0%	$1.6M-81.4%	$2.6M-74.2%	$3.3M-71.3%	-$28.6M-323.8%
Long-Term Debt	N/A	$0	N/A	$0-100.0%	$1.6M-81.2%	$2.6M-73.4%	$3.3M-70.0%	$4.0M-66.8%
Total Equity	-$7.6M+70.9%	-$11.9M+51.1%	-$26.0M	-$24.3M-7.7%	-$22.6M-112.0%	-$20.0M-302.4%	-$18.6M-1126.3%	$16.3M+39.4%
Retained Earnings	-$304.3M	-$300.6M-2.0%	N/A	-$294.6M-1.1%	-$291.4M-6.2%	-$288.6M-7.6%	-$285.0M-9.4%	-$280.6M-12.3%

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill.

ELOXD Cash Flow Statement

ELOXD quarterly cash flow statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	-$6.3M-34.2%	-$4.7M	N/A	-$31.8M+9.0%	-$35.0M-24.3%	-$28.2M+28.5%	-$39.4M-25.6%	-$31.4M-96.8%	-$15.9M-80.2%	-$8.8M-54.2%	-$5.7M-17.8%	-$4.9M-24.7%	-$3.9M+11.0%	-$4.4M+18.6%	-$5.4M
Depreciation & Amortization	$0-100.0%	$35K-69.0%	$113K+46.8%	$77K-32.5%	$114K+67.6%	$68K-21.8%	$87K-59.7%	$216K+390.1%	$44K-52.8%	$93K-47.3%	$177K-49.4%	$350K+19.1%	$294K+13.8%	$258K+80.1%	$143K
Stock-Based Compensation	$235K-56.6%	$541K-72.5%	$2.0M-35.0%	$3.0M-67.0%	$9.2M+5.8%	$8.7M-23.6%	$11.3M-15.2%	$13.4M+13137.6%	$101K+29.5%	$78K-15.2%	$92K-92.9%	$1.3M+79.0%	$725K-5.4%	$766K+2.1%	$750K
Capital Expenditures	N/A	N/A	N/A	$66K-25.8%	$89K	N/A	$40K-83.0%	$235K-0.8%	$237K+558.3%	$36K+260.0%	$10K+213.1%	$3K+149.3%	$1K-71.3%	$4K+120.2%	$2K
Free Cash Flow	N/A	N/A	N/A	-$31.9M+9.1%	-$35.1M	N/A	-$39.4M-24.8%	-$31.6M-95.4%	-$16.2M-82.1%	-$8.9M-54.6%	-$5.7M-17.9%	-$4.9M-24.8%	-$3.9M+11.1%	-$4.4M+18.6%	-$5.4M
Investing Cash Flow	$1K-97.4%	$38K-87.7%	$309K+568.2%	-$66K-103.2%	$2.1M-93.9%	$33.8M+200.8%	-$33.5M-10475.4%	-$317K-178.1%	-$114K-216.7%	-$36K-102.4%	$1.5M+129.7%	$647K+222.3%	-$529K-17.4%	-$450K+34.4%	-$686K
Financing Cash Flow	$11.0M+219.9%	$3.4M+184.2%	-$4.1M-146.3%	$8.8M-82.6%	$50.8M+1577.3%	-$3.4M-107.3%	$46.8M-16.7%	$56.2M+48.0%	$38.0M+289.8%	$9.7M+150.8%	$3.9M-55.5%	$8.7M+116.5%	$4.0M+24.9%	$3.2M+94.3%	$1.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0	$0	N/A	N/A	$15K-27.5%	$20K+117.5%	-$114K+6.4%	-$122K

Metric	Q1'2610-K	Q4'2510-K	Q1'2510-K	Q4'2410-K	Q4'2310-K	Q3'23	Q2'23	Q1'23
Operating Cash Flow	-$5.5M-552.9%	N/A	$1.2M	N/A	-$2.0M+64.5%	-$3.5M+50.3%	-$2.1M+78.8%	-$6.8M+28.2%
Depreciation & Amortization	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$15K-28.6%
Stock-Based Compensation	$46K+130.0%	N/A	$20K	N/A	N/A	$418K-41.5%	$610-18.0%	$597K-35.2%
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$0-100.0%	$0-100.0%
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$3.5M+50.7%	-$2.1M+78.8%	-$6.8M+28.3%
Investing Cash Flow	N/A	N/A	N/A	N/A	$51K	$233K+585.4%	$14K+300.0%	$11K+200.0%
Financing Cash Flow	$7.0M+912.8%	N/A	-$865K	N/A	-$1.7M-638.5%	$3.7M+144.7%	$1.4M	-$7.5M-207.1%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ELOXD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ELOXD quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Margin	N/A	-38.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-5019.9%	-59476.9%	-2705.8%	N/A
Net Margin	N/A	-49.4%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-5062.4%	-78303.4%	-2533.1%	N/A
Return on Equity	N/A	N/A	N/A	N/A	-298.1%+39.9pp	-338.0%-197.5pp	-140.5%-30.5pp	-110.0%-10.6pp	-99.3%+1515.0pp	-1614.3%-618.0pp	-996.3%-962.7pp	-33.6%+128.1pp	-161.7%-15.0pp	-146.7%+14.2pp	-160.9%
Return on Assets	-113.8%-8.1pp	-105.6%	N/A	-170.7%-22.9pp	-147.8%-17.2pp	-130.6%-44.3pp	-86.3%+6.7pp	-93.0%-7.4pp	-85.6%+229.2pp	-314.8%-273.9pp	-40.9%-13.3pp	-27.7%+58.6pp	-86.3%-13.4pp	-72.8%+11.7pp	-84.5%
Current Ratio	0.31+0.2x	0.110.0x	0.07-0.8x	0.87-3.5x	4.37+1.7x	2.63-2.3x	4.89-1.6x	6.45-0.7x	7.16+5.9x	1.23-3.5x	4.72+0.8x	3.96+2.9x	1.100.0x	1.12-0.4x	1.55
Debt-to-Equity	N/A	N/A	N/A	N/A	0.54-0.1x	0.62+0.3x	0.29+0.1x	0.180.0x	0.16-4.7x	4.86-18.5x	23.33+23.1x	0.21-0.7x	0.87-0.1x	1.01+0.1x	0.90
Asset Turnover	0.00-2.1x	2.14+2.1x	0.00	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.010.0x	0.000.0x	0.03	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-2673.2%	-49928.5%	-2195.3%	N/A

Metric	Q1'2610-K	Q4'2510-K	Q1'2510-K	Q4'2410-K	Q4'2310-K	Q3'23	Q2'23	Q1'23
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-38.2%+61.2pp
Return on Assets	-44.1%	N/A	N/A	N/A	N/A	-59.5%-31.5pp	-72.4%-40.2pp	-86.5%-59.9pp
Current Ratio	0.53	0.31+0.2x	N/A	0.110.0x	0.07-0.8x	0.24-0.9x	0.25-1.4x	0.33-1.9x
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.25-0.8x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$11.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.31), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Where ELOXD Ranks

Frequently Asked Questions

What is ELOXD's annual revenue?

ELOXD (ELOXD) reported $0 in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ELOXD's revenue growing?

ELOXD (ELOXD) revenue declined by 100.0% year-over-year, from $6.4M to $0 in fiscal year 2025.

Is ELOXD profitable?

No, ELOXD (ELOXD) reported a net income of -$6.0M in fiscal year 2025.

What is ELOXD's EBITDA?

ELOXD (ELOXD) had EBITDA of -$6.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does ELOXD have?

As of fiscal year 2025, ELOXD (ELOXD) had $4.8M in cash and equivalents against $0 in long-term debt.

What is ELOXD's operating cash flow?

ELOXD (ELOXD) recorded an outflow of $6.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are ELOXD's total assets?

ELOXD (ELOXD) had $5.3M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does ELOXD spend on research and development?

ELOXD (ELOXD) invested $3.1M in research and development during fiscal year 2025.

How many shares does ELOXD have outstanding?

ELOXD (ELOXD) had 435,432 shares outstanding as of fiscal year 2025.

What is ELOXD's current ratio?

ELOXD (ELOXD) had a current ratio of 0.31 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is ELOXD's return on assets (ROA)?

ELOXD (ELOXD) had a return on assets of -113.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is ELOXD's debt-to-equity ratio negative or not reported?

ELOXD (ELOXD) has negative shareholder equity of -$11.9M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is ELOXD's Piotroski F-Score?

ELOXD (ELOXD) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ELOXD's earnings high quality?

ELOXD (ELOXD) reported a net loss of $6.0M while operations used $6.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.